BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24441677)

  • 1. Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer.
    Brodie SA; Li G; El-Kommos A; Kang H; Ramalingam SS; Behera M; Gandhi K; Kowalski J; Sica GL; Khuri FR; Vertino PM; Brandes JC
    Cancer Prev Res (Phila); 2014 Mar; 7(3):351-61. PubMed ID: 24441677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation.
    Venza I; Visalli M; Fortunato C; Ruggeri M; Ratone S; Caffo M; Caruso G; Alafaci C; Tomasello F; Teti D; Venza M
    Epigenetics; 2012 Nov; 7(11):1315-30. PubMed ID: 23051921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.
    Benbrahim-Tallaa L; Waterland RA; Dill AL; Webber MM; Waalkes MP
    Environ Health Perspect; 2007 Oct; 115(10):1454-9. PubMed ID: 17938735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implications.
    Harada T; Ohguchi H; Grondin Y; Kikuchi S; Sagawa M; Tai YT; Mazitschek R; Hideshima T; Anderson KC
    Leukemia; 2017 Dec; 31(12):2670-2677. PubMed ID: 28490812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylation.
    Zhou Q; Atadja P; Davidson NE
    Cancer Biol Ther; 2007 Jan; 6(1):64-9. PubMed ID: 17172825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells.
    Damiani LA; Yingling CM; Leng S; Romo PE; Nakamura J; Belinsky SA
    Cancer Res; 2008 Nov; 68(21):9005-14. PubMed ID: 18974146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells.
    Zhou Q; Agoston AT; Atadja P; Nelson WG; Davidson NE
    Mol Cancer Res; 2008 May; 6(5):873-83. PubMed ID: 18505931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism.
    Ji W; Yang L; Yuan J; Yang L; Zhang M; Qi D; Duan X; Xuan A; Zhang W; Lu J; Zhuang Z; Zeng G
    Carcinogenesis; 2013 Feb; 34(2):446-53. PubMed ID: 23125218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells.
    Ceccarelli V; Ronchetti S; Marchetti MC; Calvitti M; Riccardi C; Grignani F; Vecchini A
    Biochim Biophys Acta Gene Regul Mech; 2020 Feb; 1863(2):194481. PubMed ID: 31923609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methyltransferase 1(DNMT1) induced the expression of suppressors of cytokine signaling3 (Socs3) in a mouse model of asthma.
    Verma M; Chattopadhyay BD; Kumar S; Kumar K; Verma D
    Mol Biol Rep; 2014 Jul; 41(7):4413-24. PubMed ID: 24599782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a.
    Liu WB; Cui ZH; Ao L; Zhou ZY; Zhou YH; Yuan XY; Xiang YL; Liu JY; Cao J
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):70-8. PubMed ID: 21163286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
    Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
    Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes.
    Kundakovic M; Chen Y; Guidotti A; Grayson DR
    Mol Pharmacol; 2009 Feb; 75(2):342-54. PubMed ID: 19029285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
    Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
    Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a versatile DNMT and HDAC inhibitor C02S modulating multiple cancer hallmarks for breast cancer therapy.
    Yuan Z; Chen S; Gao C; Dai Q; Zhang C; Sun Q; Lin JS; Guo C; Chen Y; Jiang Y
    Bioorg Chem; 2019 Jun; 87():200-208. PubMed ID: 30901675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone induces retinoic acid receptor β hypermethylation through DNA methyltransferase 1 accumulation in esophageal squamous epithelial cells.
    Wang J; Zhao SL; Li Y; Meng M; Qin CY
    Asian Pac J Cancer Prev; 2012; 13(5):2207-12. PubMed ID: 22901195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.
    Cacan E; Ali MW; Boyd NH; Hooks SB; Greer SF
    PLoS One; 2014; 9(1):e87455. PubMed ID: 24475290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells.
    Kim H; Ramirez CN; Su ZY; Kong AN
    J Nutr Biochem; 2016 Jul; 33():54-62. PubMed ID: 27260468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.
    Arabsolghar R; Azimi T; Rasti M
    Mol Biol Rep; 2013 Mar; 40(3):2617-25. PubMed ID: 23242655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.